The IFNγ activated CLL cells most prominently and demonstrated exceptional cytoprotective properties against venetoclax, surpassing even BCR- (PMA/ionomycin) and CD40L-mediated cytoprotection. Here, IFNG is linked to B-cell chronic lymphocytic leukemia.